Cargando…

ASGR1: an emerging therapeutic target in hypercholesterolemia

Detalles Bibliográficos
Autores principales:	Zhao, Wenqi, Xu, Suowen, Weng, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869305/ https://www.ncbi.nlm.nih.gov/pubmed/36690631 http://dx.doi.org/10.1038/s41392-023-01319-5

Ejemplares similares

Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1
por: Hoffmann, Markus, et al.
Publicado: (2021)

ASGR1 - a new target for lowering non-HDL cholesterol
por: Hassan, Mohamed, et al.
Publicado: (2016)

ASGR1 and ASGR2, the Genes that Encode the Asialoglycoprotein Receptor (Ashwell Receptor), Are Expressed in Peripheral Blood Monocytes and Show Interindividual Differences in Transcript Profile
por: Harris, Rebecca Louise, et al.
Publicado: (2012)

ASGR1 and Its Enigmatic Relative, CLEC10A
por: Hoober, J. Kenneth
Publicado: (2020)

Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis
por: Su, Meiming, et al.
Publicado: (2022)

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
por: Zhao, Yingjun, et al.
Publicado: (2022)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action
por: Su, Meiming, et al.
Publicado: (2022)

Deficiency of ASGR1 in pigs recapitulates reduced risk factor for cardiovascular disease in humans
por: Xie, Baocai, et al.
Publicado: (2021)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression
por: Xu, Yingying, et al.
Publicado: (2021)

Identifying therapeutic targets for schizophrenia
por: Montague-Cardoso, Karli
Publicado: (2021)

Haploidy in Tobacco Induced by PsASGR-BBML Transgenes via Parthenogenesis
por: Zhang, Zhifen, et al.
Publicado: (2020)

Enhanced ASGR2 by microplastic exposure leads to resistance to therapy in gastric cancer
por: Kim, Hyeongi, et al.
Publicado: (2022)

The Emergence of Carbon Isotope Exchange
por: Hinsinger, Karen, et al.
Publicado: (2019)

Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
por: Gu, Yunqing, et al.
Publicado: (2021)

Identification of ovule transcripts from the Apospory-Specific Genomic Region (ASGR)-carrier chromosome
por: Zeng, Yajuan, et al.
Publicado: (2011)

Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception
por: Roa-Colomo, Amparo, et al.
Publicado: (2022)

Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
por: Schwartz, Zander, et al.
Publicado: (2022)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)

Up in the Air: The Emerging Science of Dust and Sandstorm Microbes
por: McGrath, Casey
Publicado: (2018)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
por: Zhang, Yun, et al.
Publicado: (2020)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

The emerging roles of transplanted radial glial cells in regenerating the central nervous system
por: White, Robin E., et al.
Publicado: (2015)

Efficient and versatile manipulation of the peripheral CD4(+) T-cell compartment by antigen targeting to DNGR-1/CLEC9A
por: Joffre, Olivier P, et al.
Publicado: (2010)

The cGAS-STING pathway: a therapeutic target in chromosomally unstable cancers
por: Yan, Haiyan, et al.
Publicado: (2023)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

LARGE enzyme activity deciphered: a new therapeutic target for muscular dystrophies
por: Hewitt, Jane E
Publicado: (2012)

Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
por: Weiskirchen, Ralf
Publicado: (2023)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
por: Fu, Caiyun
Publicado: (2020)

Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target
por: Abdallah, Mohamed A., et al.
Publicado: (2020)

Constrained surfaces: promising therapeutic targets for COVID-19 determined by systematically mutational analysis
por: Wang, Manni, et al.
Publicado: (2021)

A comprehensive model for tRNA methylation modification studies
por: Weng, Qi, et al.
Publicado: (2023)

New discoveries on how DICER efficiently processes pre‐miRNA
por: Weng, Qi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i5rjgbnnogg1dgm8ckr7jtp54n